Dr Helen Partridge

Consultant in Diabetes

Specialties

Diabetes & Endocrinology

General Medicine

I trained at St Bartholomew's Hospital Medical School and undertook all my junior training in London. After MRCP I spent 3 years as a nephrology Spr and then palliative care for 2 years before settling into Diabetes and endocrinology in Wessex. After completing my training I completed a fellowship in advanced diabetes technologies at University of Toronto. I was offered a substantive consultant post in Bournemouth in 2013. I have been clinical lead there and lead for the Acute Kidney Injury service since that time.

What people can be referred for

Type 1 diabetes, Insulin pump therapy, renal diabetes, young persons' clinic

Why I chose my specialties

I enjoy the complexity of type 1 diabetes and the interplay between physical and psychological factors which influence how someone is able to manage it. The longevity of the condition allows me to build a rapport and relationship with the people I meet and support them through the changes in life associated with diabetes.

Primary contact

Secretary: Su Willis

0300 019 4610

Membership of professional bodies

BSc (Hons) Medical Biochemistry 1990

MB.BS 1995

MRCP 1998

Year of registration

1998

Special clinical interests

Type 1 diabetes education and management.

Technologies for type 1 diabetes

Lead for T1DE Compassion project looking into the development of joint physical and mental health team working for people with type 1 diabetes and an eating disorder

Lead for www.Bertieonline.org.uk

Publications

Clinical recommendations in the management of the patient with type 1 diabetes on insulin pump therapy in the perioperative period: a primer for the anaesthetist.
Partridge H, Perkins B, Mathieu S, Nicholls A, Adeniji K.
Br J Anaesth. 2016 Jan;116(1):18-26.

An unusual cause of acute kidney injury.
Humayun M, Rance C, Partridge H, Richardson T.
Br J Hosp Med (Lond). 2016 Aug 2;77(8):490-1

Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes.
Perkins BA, Cherney DZ, Soleymanlou N, Lee JA, Partridge H, Tschirhart H, Zinman B, Mazze R, Fagan N, Kaspers S, Woerle HJ, Broedl UC, Johansen OE.
PLoS One. 2015 Nov 6;10(11)

Evaluation of a clinical tool to test and adjust the programmed overnight basal profiles for insulin pump therapy: a pilot study.
Orszag A, Falappa CM, Lovblom LE, Partridge H, Tschirhart H, Boulet G, Picton P, Cafazzo JA, Perkins BA.
Can J Diabetes. 2015 Oct;39(5):364-72

Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial.
Perkins BA, Cherney DZ, Partridge H, Soleymanlou N, Tschirhart H, Zinman B, Fagan NM, Kaspers S, Woerle HJ, Broedl UC, Johansen OE.
Diabetes Care. 2014 May;37(5):1480-3

HbA1c 3 months after diagnosis predicts premature mortality in patients with new onset type 2 diabetes.
Kerr D, Partridge H, Knott J, Thomas PW.
Diabet Med. 2011 Dec;28(12):1520-4

Advantages of insulin pump therapy.
Partridge H, Kerr D.
Diabet Med. 2009 Dec;26(12):1306.

Type 1 Diabetes and Disordered eating(T1DE). The Compassion Project: Wessex. A mini review. Journal of Clinical Diabetes 2021. Allworth L, Partridge H et al 5:2

Healthcare professional awareness of eating disorders in people with type 1 diabetes: a staff survey. Brewster S, Partridge H, Cross Caroline, Price H. British Journal of Diabetes 2020: 20

Type 1 diabetes and disordered eating(T1DE);The Compassion project –Wessex. Partridge H et al. Practical Diabetes 2020;Vol 37; 127-132

Multidisciplinary healthcare teams’ challenges and strategies in supporting people with type 1 diabetes to recover from disordered eating. Zaremba N, Watson A, Kan C, Partridge H et al. Diabetic Medicine 2019

Research

Clinical outcomes of Bertieonline - an innovative online platform offering structured education to people with type 1 diabetes

EASE 3 study looking at adjunctive therapies in type 1 diabetes

Octopus study determining whether intensive diabetes management preoperativey in cardiothoracic surgery improves outcomes

Strength Study

2018 PI for Roche Solo study –a  randomised comparative study between the Roche Solo insulin pump, Omnipod insulin pump and MDI

2019 Attitudes towards availability of advice and support for people with type 1 attending university

2020 Recovery trial, Royal Bournemouth Hospital